Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Ceva launches wildlife research fund
The Ceva Wildlife Research Fund is funding the final stage of development of a chlamydia vaccine for koalas.
The first endowment fund dedicated to wildlife research.

Ceva has launched Ceva Wildlife Research Fund, a unique endowment fund to finance applied research to preserve the health of wild animals and help control the risk of zoonoses.

The global health company has pledged that the results of research supported by the fund will be visible within a maximum of three to five years.

The Ceva Wildlife Research Fund will support a number of concerns, including research into the control of diseases that occur in wildlife and tracing the origin of outbreaks. The risk of zoonotic diseases is increasing, with 75 per cent of new infectious diseases affecting humans today originating in animals - mainly wild animals.

The fund will also enable applied research to preserve biodiversity. An example of which is Ceva’s collaboration with the University of the Sunshine Coast in Brisbane, funding the final stage of development and associated testing of their chlamydia vaccine for koalas, as well as supporting additional studies to be used in the official registration process of the vaccine.

Australian authorities declared the population of East Coast koalas as a threatened species in February 2022. Their declining population may be due to the destruction of their natural habitat due to fires, increasing urbanisation, as well as chlamydia, which is having a serious impact on their reproduction and long-term survival.

President of Ceva Wildlife Research Fund Marc Prikazsky, said: "Addressing biodiversity in a holistic way is nothing new for Ceva. However, with the creation of this endowment fund, we wanted to create a separate structure to enshrine this activity. Ceva Wildlife Research Fund comes at a crucial time for research in the field. As we face an urgent need to act, we want to provide funds for innovative solutions to prevent, diagnose and treat diseases that can be transmitted from animals to humans, but also to contribute to the preservation of endangered species and to secure safer interactions between wild and farmed animals.”

Become a member or log in to add this story to your CPD history

Building Great Workplaces webinars return

News Story 1
 BVA has announced a new series of its Building Great Workplaces lunchtime webinars.

Launching from 16 July, the sessions will explore patient safety, motivation, client communication and more.

Its first webinar, exploring neurodiversity in the workplace, will take place at 1pm on Thursday, 16 July. It will feature guest speakers from The Vet Project, a group which supports neurodiversity in veterinary environments.

The following three webinars take place in September, October and November.

Booking is open on the BVA website 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.